11-58624349-A-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_000614.4(CNTF):c.430A>T(p.Ile144Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000219 in 1,613,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_000614.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNTF | NM_000614.4 | c.430A>T | p.Ile144Phe | missense_variant | 2/2 | ENST00000361987.6 | NP_000605.1 | |
ZFP91-CNTF | NR_024091.1 | n.2160A>T | non_coding_transcript_exon_variant | 13/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNTF | ENST00000361987.6 | c.430A>T | p.Ile144Phe | missense_variant | 2/2 | 1 | NM_000614.4 | ENSP00000355370.4 | ||
ZFP91-CNTF | ENST00000389919.8 | n.*402A>T | non_coding_transcript_exon_variant | 13/13 | 2 | ENSP00000455911.1 | ||||
ZFP91-CNTF | ENST00000389919.8 | n.*402A>T | 3_prime_UTR_variant | 13/13 | 2 | ENSP00000455911.1 |
Frequencies
GnomAD3 genomes AF: 0.0000922 AC: 14AN: 151798Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248904Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134736
GnomAD4 exome AF: 0.000232 AC: 339AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.000234 AC XY: 170AN XY: 727234
GnomAD4 genome AF: 0.0000922 AC: 14AN: 151916Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74252
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 20, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at